Literature DB >> 18026178

RAC reviews serious adverse event associated with AAV therapy trial.

David A Williams.   

Abstract

Mesh：

Year:  2007        PMID： 18026178     DOI： 10.1038/sj.mt.6300352

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  9 in total

1.  Chlorotoxin labeled magnetic nanovectors for targeted gene delivery to glioma.

Authors:  Forrest M Kievit; Omid Veiseh; Chen Fang; Narayan Bhattarai; Donghoon Lee; Richard G Ellenbogen; Miqin Zhang
Journal:  ACS Nano       Date:  2010-08-24       Impact factor: 15.881

Review 2.  Biological gene delivery vehicles: beyond viral vectors.

Authors:  Yiqi Seow; Matthew J Wood
Journal:  Mol Ther       Date:  2009-03-10       Impact factor: 11.454

Review 3.  Current status of ex vivo gene therapy for hematological disorders: a review of clinical trials in Japan around the world.

Authors:  Kenzaburo Tani
Journal:  Int J Hematol       Date:  2016-06-11       Impact factor: 2.490

Review 4.  Accepting risk in clinical research: is the gene therapy field becoming too risk-averse?

Authors:  Claire T Deakin; Ian E Alexander; Ian Kerridge
Journal:  Mol Ther       Date:  2009-09-22       Impact factor: 11.454

Review 5.  Gene therapy using adeno-associated virus vectors.

Authors:  Shyam Daya; Kenneth I Berns
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

6.  Retargeting transposon insertions by the adeno-associated virus Rep protein.

Authors:  Ismahen Ammar; Andreas Gogol-Döring; Csaba Miskey; Wei Chen; Toni Cathomen; Zsuzsanna Izsvák; Zoltán Ivics
Journal:  Nucleic Acids Res       Date:  2012-04-19       Impact factor: 16.971

Review 7.  Clinical potential and challenges of using genetically modified cells for articular cartilage repair.

Authors:  Henning Madry; Magali Cucchiarini
Journal:  Croat Med J       Date:  2011-06       Impact factor: 1.351

Review 8.  Gene Therapy for Cartilage Repair.

Authors:  Henning Madry; Patrick Orth; Magali Cucchiarini
Journal:  Cartilage       Date:  2011-07       Impact factor: 4.634

Review 9.  TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease.

Authors:  Melissa K McCoy; Malú G Tansey
Journal:  J Neuroinflammation       Date:  2008-10-17       Impact factor: 8.322
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.